# ApoA-I Synthesis Stimulation and Intravascular Ultrasound for Coronary Atheroma Regression Evaluation

Study · id `cardio:ct-nct01067820` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01067820](<https://clinicaltrials.gov/study/NCT01067820>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01067820

Browse, organ or system: Heart; Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 324 participants.

## Technical summary

Registry record NCT01067820. Randomized; triple masking; primary purpose treatment. Start 2011-09 (registry gives no type); primary completion 2013-05 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 324 participants (enrolled count; ClinicalTrials.gov record NCT01067820, source copy `cardio:ctgov-nct01067820-2013-06-04`, retrieved 2026-10-26)
- Start date: 2011-09 (registry gives no type) (ClinicalTrials.gov record NCT01067820, source copy `cardio:ctgov-nct01067820-2013-06-04`, retrieved 2026-10-26)
- Primary completion: 2013-05 (actual) (ClinicalTrials.gov record NCT01067820, source copy `cardio:ctgov-nct01067820-2013-06-04`, retrieved 2026-10-26)
- Completion: 2013-06 (actual) (ClinicalTrials.gov record NCT01067820, source copy `cardio:ctgov-nct01067820-2013-06-04`, retrieved 2026-10-26)
- Countries: Argentina; Belgium; Brazil; Hungary; Netherlands; Poland; Russia; Spain (ClinicalTrials.gov record NCT01067820, source copy `cardio:ctgov-nct01067820-2013-06-04`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01067820-2013-06-04`, retrieved 2026-10-26)

## The registry's words

- Brief title: ApoA-I Synthesis Stimulation and Intravascular Ultrasound for Coronary Atheroma Regression Evaluation
- Acronym: ASSURE I
- Condition: Coronary Artery Disease
- Intervention (Drug): RVX000222
- Intervention (Drug): Placebo RVX000222
- Lead sponsor: Resverlogix Corp
- Lead sponsor class: INDUSTRY
- Collaborator: The Cleveland Clinic
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Atherosclerosis (`cardio:atherosclerosis`)
- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry lists this organization as the lead sponsor: Resverlogix Corp (`cardio:org-resverlogix-corp`)
- Registry lists this organization as a collaborator: The Cleveland Clinic (`cardio:org-the-cleveland-clinic`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Effect of the BET Protein Inhibitor, RVX-208, on Progression of Coronary Atherosclerosis: Results of the Phase 2b, Randomized, Double-Blind, Multicenter, ASSURE Trial (`cardio:pubmed-26385396`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 649aa73d68855a3b481c19f4707da3951e61a56dcd1f0efa4e16976d64b7529d
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
